S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:PDEX

Pro-Dex - PDEX Stock Forecast, Price & News

$17.50
+0.27 (+1.57%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.33
▼
$17.50
50-Day Range
$15.80
▼
$18.00
52-Week Range
$12.40
▼
$26.50
Volume
1,717 shs
Average Volume
5,638 shs
Market Capitalization
$62.65 million
P/E Ratio
16.83
Dividend Yield
N/A
Price Target
$30.00

Pro-Dex MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
71.4% Upside
$30.00 Price Target
Short Interest
Healthy
0.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of Pro-Dex in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

Medical Sector

903rd out of 1,053 stocks

Surgical & Medical Instruments Industry

94th out of 105 stocks

See Top Rated MarketRank™ Stocks Here

PDEX stock logo

About Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

February 2, 2023 | americanbankingnews.com
Pro-Dex (NASDAQ:PDEX) Now Covered by Analysts at StockNews.com
January 30, 2023 | seekingalpha.com
Pro-Dex Is Growing But Expensive Given Its Risk
February 2, 2023 | Tradewins (Ad)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
January 25, 2023 | americanbankingnews.com
Pro-Dex (NASDAQ:PDEX) Receives New Coverage from Analysts at StockNews.com
January 20, 2023 | finance.yahoo.com
Why Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth Watching
January 18, 2023 | reuters.com
PDEX.A - | Stock Price & Latest News | Reuters
December 21, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 19% CAGR over the last five years
November 25, 2022 | msn.com
Pro-Dex Earnings Perspective: Return On Invested Capital
February 2, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
November 23, 2022 | finance.yahoo.com
Declining Stock and Solid Fundamentals: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)?
November 9, 2022 | finance.yahoo.com
Pro-Dex First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
November 4, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results
October 22, 2022 | finance.yahoo.com
Quite a few insiders invested in Pro-Dex, Inc. (NASDAQ:PDEX) last year which is positive news for shareholders
October 17, 2022 | nasdaq.com
Pro-Dex (NASDAQ:PDEX) May Have Issues Allocating Its Capital
September 29, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses Record-Breaking 4th Quarter Results and Year-Over-Year Growth with The Stock Day Podcast
September 26, 2022 | seekingalpha.com
Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
September 20, 2022 | finance.yahoo.com
Some Investors May Be Worried About Pro-Dex's (NASDAQ:PDEX) Returns On Capital
August 25, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2022 Fourth Quarter And Full-Year Results
August 6, 2022 | reuters.com
Pro-Dex Inc
July 31, 2022 | nasdaq.com
Here's Why Pro-Dex (NASDAQ:PDEX) Has A Meaningful Debt Burden
July 14, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 21% CAGR over the last five years
June 14, 2022 | finance.yahoo.com
Pro-Dex, Inc. (NASDAQ:PDEX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
June 6, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses 2022 Goals and Third Quarter Results with The Stock Day Podcast
May 15, 2022 | finance.yahoo.com
A number of insiders bought Pro-Dex, Inc. (NASDAQ:PDEX) stock last year, which is great news for shareholders
May 12, 2022 | seekingalpha.com
PDEX and DPSI among mid-day movers
May 5, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2022 Third Quarter and Nine-Month Results
April 13, 2022 | finance.yahoo.com
Pro-Dex's (NASDAQ:PDEX) Returns On Capital Are Heading Higher
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Company Calendar

Last Earnings
11/15/2021
Today
2/02/2023
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
6/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PDEX
CUSIP
N/A
CIK
788920
Web
www.pro-dex.com
Phone
(949) 769-3200
Fax
949-769-3281
Employees
117
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+71.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.04
Trailing P/E Ratio
16.83
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.86 million
Net Margins
8.97%
Pretax Margin
10.73%
Return on Equity
16.75%
Return on Assets
8.53%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
2.73
Quick Ratio
1.39

Sales & Book Value

Annual Sales
$42.04 million
Price / Sales
1.49
Cash Flow
$1.31 per share
Price / Cash Flow
13.34
Book Value
$6.54 per share
Price / Book
2.68

Miscellaneous

Outstanding Shares
3,580,000
Free Float
2,055,000
Market Cap
$62.65 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Richard Lee van Kirk
    President, Chief Executive Officer, COO & Director
  • Alisha K. CharltonAlisha K. Charlton
    Chief Financial Officer & Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions













PDEX Stock - Frequently Asked Questions

What is Pro-Dex's stock price forecast for 2023?

0 Wall Street analysts have issued 1-year target prices for Pro-Dex's stock. Their PDEX share price forecasts range from $30.00 to $30.00. On average, they expect the company's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 71.4% from the stock's current price.
View analysts price targets for PDEX or view top-rated stocks among Wall Street analysts.

How have PDEX shares performed in 2023?

Pro-Dex's stock was trading at $15.90 at the beginning of 2023. Since then, PDEX stock has increased by 10.1% and is now trading at $17.50.
View the best growth stocks for 2023 here.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our PDEX earnings forecast.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) posted its quarterly earnings data on Monday, November, 15th. The medical instruments supplier reported $0.28 earnings per share for the quarter, meeting the consensus estimate of $0.28. The medical instruments supplier earned $9.99 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 16.75% and a net margin of 8.97%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $17.50.

How much money does Pro-Dex make?

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $62.65 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.04 on an earnings per share basis.

How many employees does Pro-Dex have?

The company employs 117 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.

This page (NASDAQ:PDEX) was last updated on 2/2/2023 by MarketBeat.com Staff